Metraipolis › archive › dc_25971be37b0c

Use of Rituximab in a Sjogren's Disease-Associated Inflammatory Pseudotumor: A Case Report — Europe PMC PMID:42798966

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42798966
DOI
10.1155/crrh/9145050
License (as archived)
solo-consultazione
Archived
2026-10-07T22:05:45.501Z
SHA-256 of the archived text
dbf4034098d5e3bbbe06a304e4e36c8251f59c10077ef9f8e440a522d27046ea
Stable URL of this page
https://metraipolis.com/documento/dc_25971be37b0c

How to cite

Use of Rituximab in a Sjogren's Disease-Associated Inflammatory Pseudotumor: A Case Report — Europe PMC PMID:42798966 — Europe PMC (en), https://europepmc.org/article/MED/42798966 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_25971be37b0c (Metraipolis archive dc_25971be37b0c, sha256 dbf4034098d5e3bbbe06a304e4e36c8251f59c10077ef9f8e440a522d27046ea)
BibTeX
@misc{dc25971be37b0c,
  title = {Use of Rituximab in a Sjogren's Disease-Associated Inflammatory Pseudotumor: A Case Report — Europe PMC PMID:42798966},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42798966},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_25971be37b0c; sha256 dbf4034098d5e3bbbe06a304e4e36c8251f59c10077ef9f8e440a522d27046ea},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42798966. Agents can read the archived copy with the MCP tool read_document.